33

DAFTAR PUSTAKA

1. Dan L Longo, Dennis L Kasper, J Larry Jameson, Anthony S Fauci, Stephen L

Hauser, Joseph Loscalzo. Harrison’s Principles of internal medicine. USA:

The McGraw-Hill Companies; 2012.

2. Undurti N Das. Insulin in Sepsis and Septic Shock. JAPI. 2003; 51:695-700.

3. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F,

Schietz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouikkon R. Intensive

Insulin Therapy in Critically Ill Patients. N Engl J Med. 2001; 345: 1359-67.

4. Jonathan Cohen. The immunopathogenesis of sepsis. Nature [Internet]. 2002

[cited 2012 October 8]; 420:885-91. Available from: www.nature.com/nature.

5. F Wong, M Bernardi, R Balk, B Christman, R Moreau, G Garcia-Tsao, et al.

Sepsis in cirrhosis: report on the 7th

meeting of the International Ascites Club.

Gut [Internet].2005 [cited 2012 December 24]; 54:718-725. Available from:

gut.bml.com.

6. Arthur C Guyton, John E Hall. Buku ajar fisiologi kedokteran. Jakarta: EGC;

2007.

7. Anselm O Agwunobi, Claire Reid, Paula Maycock, Roderick A Little, Gordon

L Carlson. Insulin Resistence and Substrate Utilization in Human

Endotoxemia. JCE & M. 2000; 85: 3770-3778.

8. Armella Mathonet, Alain Cariou. Glycemic Control in Sepsis. Adv Sepsis.

2007; 6(1):16-18.

34

9. Paul E Marik, Murugen Raghavan. Stress-hyperglycemia, insulin and

immunomodulation in sepsis. Intensive Care Med. 2004; 30: 748-56.

10. Alain Cariou, Christophe Vinsonneau, Jean-Francois Dhainaut. Adjunctive

therapies in sepsis: An evidence-based review. Crit Care Med.

2004;32(11):S562-S570.

11. Eric A J Hoste, Norbert H Lameire, Raymond C Vanholder, Dominique D

Benoit, Johan M A Decruyenaere, Francis A Colardyn. Acete Renal Failure in

Patients with Sepsis in a Surgical ICU: Predictive Factor, Incidence,

Comorbidity, and Outcome. J Am Soc Nephrol.2003; 14:1022-30.

12. Greg S Martin, Stephanie Eaton, Meredith Mealer, Marc Moss. Extravascular

lung water in patients with severe sepsis: a prospective cohort study. Critical

Care [Internet]. 2005 [cited 2012 December 24]; 9(2): R74-R82. Available

from: http://ccforum.com/content/9/2/R74

13. Andreas Hillenbrand, Manfred Weiss, Uwe Knippschild, Anna Maria Wolf,

Markus Huber-Lang. Sepsis-induced adipokine change with regard to insulin

resistance. International Journal of Inflamation. 2012:1-7.

14. Can Ince. The microcirculation is the motor of sepsis. Critical Care [Internet].

2005 [cited 2012 December 24]; 9(suppl 4): S13-S19. Available from:

http://ccforum.com/supplements/9/S4/S13.

15. Soren Kaeseler Andersen, Jakob Gjedsted, Christian Christiansen, Else

Tonnesen. The roles of insulin and hyperglycemia in sepsis pathogenesis.

Journal of Leukocyte Biology. 2004; 75: 413-21.

16. Abdulaziz S Aldawood, Hani M Tamim, Mohammed A Alsultan, Asgar H

Rishu, Yaseen M Arabi. Intensive insulin therapy versus conventional insulin

35

therapy for critically ill trauma patients admitted to ICU. M E J Anesth

[Internet]. 2010 [cited 2013 January 24]; 20(5): 659-66. Available from:

http://www.meja.aub.edu.lb/20_5.html

17. Abbas E Kitabchi, Guillermo E Umpierrez, Mary Beth Murphy, Eugene J

Barrett, Robert A Kreisberg, Johan I Malone, et al. Management of

hyperglycaemic crises in patients with diabetes. Diabetes Care. 2001; 24: 131-

53.

18. John Koskinas, Ilias P Gomatos, Dina G Tiniakos, Nikolas Memos, Maria

Boutsikou, Aspasia Garatzioti, Athanasios Archimandritis, et al. Liver

histology in ICU patients dying from sepsis: A clinic-pathological study.

World J Gastroenterol. 2008 [Internet]. 2008 [cited 2013 January 22];

14(9):1389-93. Available from: www.wjgnwt.com

19. Herbert Spapen. Liver perfusion in sepsis, septic shock, and multiorgan

failure. The Anatomical Record [Internet]. 2008 [cited 2013 January 22];

291:714-20. Available from: Wiley Interscience.

20. Robert KM, Daryl KG, Victor WR. Biokimia harper. Jakarta: EGC; 2009.

21. Sacha Zeerleder, Erik Hack, Walter A Wuillemin. Disseminated Intravascular

Coagulation in Sepsis. CHEST [Internet]. 2005 [cited 2013 January 3];

128:2864-75. Available from: http://journal.publications.chestnet.org/

22. Frank M Brunkhorst, Christoph Engel, Frank Bloos, et al. Intensive Insulin

Therapy and Pentastarch Resuscitation in Severe Sepsis. N Engl J Med. 2008;

358: 125-39.

23. Sidharta Das, Bijay Misra. Insulin Resistance as Prognostic Indicator in Multi

Organ Dysfunction Syndrome. Medicine Update. 2011: 420-426.

36

24. Ricardo Gracia Branco, Robert Charles Tasker, Pedro Celiny Ramos Gracia,

et al. Glycemic control and insulin therapy in sepsis and critical illness. Jurnal

de Pediatria. 2007; 83(Suppl 5): S128-S136.

25. Zdenek Rusavy, Vladimir Sramek, Silvie Lacigova, et al. Influence of insulin

on glucose metabolisme and energy expenditure in septic patients. Critical

Care. 2004; 8: R213-R220.

26. Tri Murti Andayani, Mohamed Izham Mihemed Ibrahim, Ahmad H Asdie.

Comparison of the glycemyc control of insulin and triple oral therapy in type 2

diabetes mellitus. Journal of Diabetes and Endocrinology. 2010: 1 (2): 13-18.

37

Lampiran

Descriptive Statistics

N Minimum Maximum Mean Std. Deviation

Jenis Kelamin Pasien 22 1 2 1.41 .503

Usia Pasien 22 34 79 55.64 12.894

GDS Sebelum Pemberian

Insulin

22 100 585 279.41 130.912

GDS Sesudah Pemberian

Insulin

22 62 401 205.91 85.383

Valid N (listwise) 22

Case Processing Summary

Cases

Valid Missing Total

N Percent N Percent N Percent

GDS Sebelum Pemberian

Insulin

22 100.0% 0 .0% 22 100.0%

GDS Sesudah Pemberian

Insulin

22 100.0% 0 .0% 22 100.0%

38

Jenis Kelamin Pasien

Frequency Percent Valid Percent

Cumulative

Percent

Valid Laki-laki 13 59.1 59.1 59.1

Perempuan 9 40.9 40.9 100.0

Total 22 100.0 100.0

Descriptives

Statistic Std. Error

GDS Sebelum Pemberian

Insulin

Mean 279.41 27.910

95% Confidence Interval for

Mean

Lower Bound 221.37

Upper Bound 337.45

5% Trimmed Mean 272.76

Median 280.00

Variance 17137.872

Std. Deviation 130.912

Minimum 100

Maximum 585

Range 485

Interquartile Range 215

Skewness .671 .491

Kurtosis -.184 .953

39

Tests of Normality

Kolmogorov-Smirnov

a Shapiro-Wilk

Statistic df Sig. Statistic df Sig.

GDS Sebelum Pemberian

Insulin

.144 22 .200* .945 22 .248

GDS Sesudah Pemberian

Insulin

.096 22 .200* .959 22 .476

a. Lilliefors Significance Correction

*. This is a lower bound of the true significance.

GDS Sesudah Pemberian

Insulin

Mean 205.91 18.204

95% Confidence Interval for

Mean

Lower Bound 168.05

Upper Bound 243.77

5% Trimmed Mean 203.00

Median 199.00

Variance 7290.277

Std. Deviation 85.383

Minimum 62

Maximum 401

Range 339

Interquartile Range 107

Skewness .638 .491

Kurtosis .221 .953

40

41

Paired Samples Statistics

Mean N Std. Deviation Std. Error Mean

Pair 1 GDS Sebelum Pemberian

Insulin

279.41 22 130.912 27.910

GDS Sesudah Pemberian

Insulin

205.91 22 85.383 18.204

42

Paired Samples Correlations

N Correlation Sig.

Pair 1 GDS Sebelum Pemberian

Insulin & GDS Sesudah

Pemberian Insulin

22 .839 .000

Paired Samples Test

Paired Differences

t df

Sig. (2-

tailed)

Mean

Std.

Deviation

Std. Error

Mean

95% Confidence Interval

of the Difference

Lower Upper

Pair 1 GDS Sebelum

Pemberian Insulin -

GDS Sesudah

Pemberian Insulin

73.500 75.299 16.054 40.114 106.886 4.578 21 .000

43

IDENTITAS

Nama : Desriyan Purnama Putra

NIM : G2A009076

Tempat/Tanggal Lahir : Rimbo Bujang/ 23 Desember 1991

Jenis Kelamin : Laki-laki

Alamat : Jalan Bukit Kelapa Sawit VII AD 27 Tembalang

No Telepon : -

No HP : 085266923213

Email : desriyan@gmail.com

Riwayat Pendidikan Formal

1. SD : SD 81/VIII Lulus Tahun: 2003

2. SMP : SMP N 3 Tebo Lulus Tahun: 2006

3. SMA : SMA N 2 Tebo Lulus Tahun: 2009

4. FK Undip : Masuk Tahun: 2009

Keanggotaan Organisasi

Anggota Maladica ( Mahasiswa Pecianta Alam Medica) FK Undip sejak 2010

Pengalaman Penelitian

Pengalaman Publikasi Tulisan Ilmiah

Pengalaman Presentasi Karya Tulis Ilmiah

Pengalaman Mengikutai Lomba Karya Ilmiah

44